10 aug 2021
CPhI North America 2021

About us

AbbVie Contract Manufacturing has been serving as a trusted partner for more than 40 years across ten of our manufacturing facilities located in both North America and Europe. Our contract development and manufacturing capabilities span both small and large molecule API including classical fermentation, chemical synthesis, biologics and ADCs. In addition to APIs, we are offering extensive experience and technical solutions in drug product manufacturing which includes traditional tablet and capsule production, potent, hot melt extrusion and aseptic fill finish.  Lastly, we can also package your product regionally.  

By choosing AbbVie Contract Manufacturing, your team gets so much more than the typical CMO engagement. Alongside our state of the art cGMP manufacturing facilities, AbbVie's partners gain integrated access to deep scientific expertise and processes that have successfully supported many small molecule and biologic medicines through to commercialization.

Specs about this supplier

Sales markets Oceania; North America (USA, Canada); Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia)
Affiliated categories: Antibiotics |Antibody Drug Conjugates (ADCs) |API Contract Manufacturing More

Products featured at CPhI North America 2021


Event information

CPhI North America 2021

August 10-12 2021 Philadelphia, USA Visit us at stand 2112